GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Price-to-Owner-Earnings

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Price-to-Owner-Earnings

: (As of Today)
View and export this data going back to . Start your Free Trial

As of today (2024-04-23), Carl Zeiss Meditec AG's share price is $97.95. Carl Zeiss Meditec AG does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Carl Zeiss Meditec AG's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Carl Zeiss Meditec AG was 120.26. The lowest was 18.41. And the median was 43.08.


CZMWF's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 31.17
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-23), Carl Zeiss Meditec AG's share price is $97.95. Carl Zeiss Meditec AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.34. Therefore, Carl Zeiss Meditec AG's PE Ratio for today is 29.34.

As of today (2024-04-23), Carl Zeiss Meditec AG's share price is $97.95. Carl Zeiss Meditec AG's EPS without NRI for the trailing twelve months (TTM) ended in was $3.34. Therefore, Carl Zeiss Meditec AG's PE Ratio without NRI for today is 29.34.

During the past 13 years, Carl Zeiss Meditec AG's highest PE Ratio without NRI was 94.73. The lowest was 18.02. And the median was 34.33.


Carl Zeiss Meditec AG Price-to-Owner-Earnings Historical Data

The historical data trend for Carl Zeiss Meditec AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Owner-Earnings
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.67 97.64 - - -

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG Price-to-Owner-Earnings Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Price-to-Owner-Earnings falls into.



Carl Zeiss Meditec AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Carl Zeiss Meditec AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=97.95/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Carl Zeiss Meditec AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.